Mesoblast Limited (MSB.AX) Reports Positive Type 2 Diabetes Trial Results
12/4/2013 7:12:15 AM
More...
|
FDA Clears Commencement of Phase 3 Chronic Heart Failure Trial Using Mesoblast Limited (MSB.AX)'s Proprietary Cells
10/31/2013 10:22:34 AM
More...
|
Mesoblast Limited (MSB.AX) Updates Market on Registration Plans for GVHD Cell Product in Japan
10/28/2013 9:52:53 AM
More...
|
Mesoblast Limited (MSB.AX), Intrexon Corporation and ZIOPHARM Oncology, Inc. (ZIOP.OB) to Target Cancers
10/23/2013 10:03:13 AM
More...
|
Mesoblast Limited (MSB.AX) Snags Osiris Therapeutics, Inc. (OSIR)'s Stem Cell Assets for Up to $100 Million
10/11/2013 7:27:59 AM
More...
|
Mesoblast Limited's Phase 2 Trial For Lumbar Spinal Fusion Selected For Presentation at Premier Spine Conference
9/19/2013 9:41:16 AM
More...
|
Mesoblast Limited's Strong Cash Position Enables Execution of Late-Stage Clinical Trials
8/29/2013 9:57:51 AM
More...
|
Mesoblast Limited Receives $4.3 Million From Australian Government for Adult Stem Cell Pipeline Development
7/18/2013 9:23:17 AM
More...
|
Mesoblast Limited Receives Clearance to Begin Phase 2 Clinical Trial of Mesenchymal Precursor Cells in Diabetic Nephropathy
6/26/2013 9:34:45 AM
More...
|
Mesoblast Limited's Preclinical Trial Results of Intracoronary Cell Therapy Published in Circulation Research
5/15/2013 9:31:16 AM
More...
|
|